1352640-87-9

Upstream product

• 1233956-56-3 Gd(III)-1,4,7,10-tetraazacyclododecane-1-glutaric acid-4,7,10-triacetic acid 
• 1352204-63-7 C₂₃H₂₅N₃O₂ 
• 1352204-62-6 tert-butyl 4-(2-((3-phenylpropanoyloxy)methyl)quinolin-7-yl)piperazine-1-carboxylate 
• 1352204-61-5 tert-butyl 4-((2-hydroxymethyl)quinolin-7-yl)piperazine-1-carboxylate 

Downstream Products

• 1352640-91-5 Gd⁽³⁺⁾*(CH₂CH₂NCH₂COO)3(CH₂CH₂NCH(COO)CH₂CH₂CON(CH₂)4NC₉H₅NCH₂OH)^(4-)=GdC₃₃H₄₃N₇O₁₀^(1-) 
• 501-52-0 3-Phenylpropionic acid 

Relevant academic research and scientific papers

X-RAY AND GAMMA-PHOTON ACTIVABLE ORGANIC COMPOUNDS, THEIR PREPARATION AND THEIR USES

The present invention relates to a X-ray and gamma-photon activable compound responding to the following formula (I). The present invention also relates to methods of synthesizing a compound according to the invention, and to an aqueous or physiological solution comprising at least one compound of the invention. The present invention also concerns a method of liberating a biologically active compound, said method involving the step of irradiating at least one compound, or at least one aqueous or physiological solution according to the invention. Finally, the present invention relates to a pharmaceutical composition comprising at least one compound, or at least one aqueous or physiological solution according to the invention.

X-ray photolysis to release ligands from caged reagents by an intramolecular antenna sensitive to magnetic resonance imaging

Sensitive to light: A metal-complex-sensitized organic probe was developed to release ligands on excitation by X-ray or γ irradiation (see picture). This overcomes a current limitation in permitting use of photolysis as an experimental tool in otherwise inaccessible materials that are not penetrated by light (ET=electron transfer). Copyright